Skip to main content

Published locations for Early breast cancer: Adding capecitabine prolongs survival in 15-year FinXX trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Early breast cancer: Adding capecitabine prolongs survival in 15-year FinXX trial

User login

  • Reset your password
  • /content/early-breast-cancer-adding-capecitabine-prolongs-survival-15-year-finxx-trial
  • /hematology-oncology/article/252018/breast-cancer/early-breast-cancer-adding-capecitabine-prolongs
  • /breast-cancer-icymi/article/252018/breast-cancer/early-breast-cancer-adding-capecitabine-prolongs